In eligible researches, the experiment group was treated with SFI alone or combined with conventional western medicine (all guideline-recommended drugs: Angiotensin-converting enzyme inhibitors, β- blocker, angiotensin II receptor blockers, etc., administered alone or in combination), There were no restrictions on frequency and duration at first, because we will conduct subgroup analysis according them if they had a high heterogeneity. The comparison treatment in control group could be conventional medication alone or even placebo treatment.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.